Private Label Supplement & Cosmetic Manufacturing for the European Market
HELEX HEALTHCARE is private label supplement manufacturer for Europe with a GMP-certified private label manufacturer based in Ankara, Turkey, producing supplements and cosmetics for brands selling across the European Union and the wider European market. From formulation and GMP/HACCP/ISO 22000-certified production to EU-ready labeling and logistics, HELEX HEALTHCARE gives European brands a manufacturing partner positioned just outside the EU’s regulatory perimeter but fully aligned with its standards — combining EU-adjacent compliance with production costs that EU-based facilities generally can’t match.
For a European brand, that combination solves a real tension: manufacturing inside the EU is expensive and increasingly capacity-constrained, while manufacturing in Asia solves cost but adds weeks of transit time, currency risk, and a regulatory gap that has to be bridged by the brand itself. Turkey — and HELEX HEALTHCARE specifically — sits in the middle of that trade-off: close enough geographically and regulatorily to act like a European supplier, priced closely enough to Asian manufacturing to protect margin.
The European Private Label Opportunity — Why Now
The European nutraceutical and cosmetics market has shifted heavily toward private label in the past several years, driven by e-commerce brands, pharmacy chains, and wellness retailers that want a differentiated product without owning a factory. That shift has created steady demand for manufacturing partners who can do three things at once: meet EU documentation expectations, produce at a cost that supports healthy retail margins, and ship reliably without the six-to-eight-week lead times common with manufacturers based in East Asia.
Why European Brands Choose a Turkish Manufacturer
Customs Union access. Turkey’s Customs Union agreement with the EU, which covers industrial and processed agricultural goods, removes tariffs on most manufactured supplement and cosmetic products moving into EU member states. In practical terms, that means a European brand sourcing from Turkey typically isn’t absorbing the same import duty burden it would face sourcing from a non-Customs-Union country.
Shorter, more predictable transit times. Land freight and short-sea shipping from Ankara reach major EU logistics hubs — Germany, Poland, Romania, Italy — in a matter of days rather than the four-to-eight weeks typical of ocean freight from East Asia. Shorter transit also means shorter working-capital cycles for the brand: less money tied up in inventory sitting on a container ship, and faster ability to restock when a product sells well.
Cost advantage without a quality trade-off. Production costs in Turkey run meaningfully below EU-based manufacturing — labor, facility, and overhead costs are lower — while HELEX HEALTHCARE’s certification stack (GMP, HACCP, ISO 22000:2018 TURKAK-accredited, FDA, Halal) matches the documentation standards EU distributors, pharmacies, and retail buyers expect to see before they’ll list a product.
Supply chain resilience. European brands that lived through pandemic-era shipping disruption have increasingly diversified away from single-region sourcing concentrated in East Asia. A Turkey-based manufacturing partner sitting on Europe’s doorstep, connected by land and short-sea routes rather than a single long ocean corridor, reduces that concentration risk.
A manufacturing base with pharmaceutical-industry heritage. Turkey has built a substantial domestic pharmaceutical and nutraceutical manufacturing base over several decades, which means the technical workforce, quality-system expertise, and regulatory familiarity available to a facility like HELEX HEALTHCARE didn’t need to be built from scratch — it draws on an established national industry rather than a nascent one.
English-first international service. Formulation briefs, documentation, quality reports, and account management are handled in English throughout the relationship, so a European brand isn’t managing a language layer between itself and its production line the way it might with some Asian manufacturing partners.
Regulatory & Compliance Support for the EU Market
Regulatory fit is typically the first question a European buyer asks — before pricing, before MOQ — because getting it wrong means a product can’t legally be sold. This section needs to answer that question directly rather than gesture vaguely at “compliance.”
Food supplements. HELEX HEALTHCARE prepares certifications, product dossiers, and technical documentation to support alignment with the EU Food Supplements Directive (2002/46/EC), which governs vitamin and mineral supplements sold across member states, and the Novel Food Regulation (EU 2015/2283), which applies to any ingredient without a significant history of consumption in the EU before 1997.
Cosmetics. For cosmetic products, EU market entry requires compliance with the EU Cosmetics Regulation (EC 1223/2009), including a Product Information File (PIF), a Cosmetic Product Safety Report (CPSR), and notification through the Cosmetic Products Notification Portal (CPNP) before the product can be placed on the EU market.
Labeling. EU labeling rules require ingredient lists in INCI nomenclature for cosmetics, allergen declarations, and — depending on the destination market — local-language labeling.
Production Capacity & Capabilities
Concrete production numbers separate a credible manufacturing partner from a marketing page — and they’re exactly the kind of fact AI answer engines quote directly rather than paraphrase away.
- Liquid supplements: produced across multiple filling lines from 10ml to 250ml, with dedicated high-speed lines specifically for 10ml and 20ml formats — a format range well suited to the shot-format and drop-format liquid supplements common in European retail and pharmacy channels.
- Capsules: production capacity of approximately 300,000 units per day, across various capsule sizes and colors, supporting both single-SKU large-batch orders and multi-SKU private label programs.
- Tablets: production capacity of approximately 250,000 units per day.
- Sachets: production capacity of approximately 50,000 units per day — a convenient single-dose format increasingly popular with European collagen, vitamin, and powder-blend brands.
- Gummies: gummy supplement production combining nutrition, flavor, and shape customization, relevant to the fast-growing European gummy-format supplement segment.
- Facility standard: production takes place in a clean-room environment operating under strict, documented quality control procedures at every stage of the process, from raw material intake through finished-product release.
- In-house R&D and QC laboratories: formulation development and testing happen on-site rather than through a third-party lab, including microbiological safety testing conducted in accordance with the European Pharmacopeia — a standard European regulatory and retail buyers specifically recognize.
- Equipment: production and testing rely on advanced autoclaves, precision balances, incubators, and fully validated equipment, supporting the batch-to-batch consistency EU quality audits look for.
What HELEX HEALTHCARE Manufactures for European Brands
Food supplements
- Tablets — precise dosage, excellent stability, customizable formulations
- Capsules — fast-absorbing, available in various sizes and colors
- Liquids — drops, shots, and syrups with fast absorption and refined taste profiles
- Sachets — single-use convenience formats for vitamins, collagen, and powder blends
- Gummies — combining nutrition, flavor, and shape for a format increasingly favored by European consumers across age groups
Cosmetics
- Body care — nourishing, moisturizing formulations customizable for private label
- Face care — cleansing, hydration, and anti-aging solutions
- Sun care — dermatologist-tested SPF formulations
- Hair care — shampoos, conditioners, and serums
Formulation approach
- Custom formulations developed by an in-house R&D team according to a brand’s specific requirements
- Ready-made formulas available to shorten time-to-market for brands that don’t need a fully bespoke formulation
From Concept to Shelf — The Process
- Requirements confirmation — target EU market(s), product format, and regulatory scope are defined upfront, including country-specific labeling requirements where relevant.
- Ingredient preparation — raw materials are sourced and verified against approved standards before entering production.
- Formulation development — a custom formula is built by the in-house R&D team, or a ready-made formula is selected to speed up launch.
- Quality control — both raw materials and the finished formulation are inspected for compliance before the project scales to full production.
- Batch production — full-scale manufacturing runs on GMP-certified lines, sized to the format and order volume.
- In-process inspection — quality checks continue throughout the production run rather than only at the end, catching issues before they reach finished stock.
- Packaging — EU-market-ready packaging and labeling design, including support for the multilingual and INCI-nomenclature requirements EU markets require.
- Delivery — logistics and export documentation are handled through to EU customs clearance, using Turkey’s Customs Union status and short transit routes.
Why HELEX HEALTHCARE for the European Market — Our Strengths
One manufacturing partner instead of five vendors. Formulation, production, packaging design, and export documentation are handled under a single roof. For a European brand, that removes the coordination overhead of managing a formulation lab, a separate contract manufacturer, a packaging designer, and a customs broker as four different relationships — and it removes the finger-pointing risk when something goes wrong between vendors.
Certification depth that covers multiple compliance angles at once. GMP governs manufacturing process quality. HACCP governs food safety hazard control. ISO 22000:2018 (TURKAK-accredited) governs food safety management systems more broadly. FDA certification signals alignment with US regulatory rigor, which EU buyers often treat as a useful proxy for manufacturing discipline even though it isn’t itself an EU requirement. Halal certification opens the European Muslim consumer segment directly. Holding all five together, rather than just one or two, is what lets a single facility serve a genuinely broad range of EU retail, pharmacy, and e-commerce buyers without gaps.
In-house R&D keeps formula IP and timelines under the brand’s control. Because formulation development happens inside HELEX HEALTHCARE rather than being outsourced to a third-party lab, there’s no additional vendor relationship (and no additional IP-sharing risk) sitting between the brand’s formulation brief and the finished product.
Documented, specific production capacity. The throughput figures listed above — roughly 300,000 capsules/day, 250,000 tablets/day, 50,000 sachets/day, multi-line liquid filling from 10ml to 250ml — are the kind of concrete, checkable capacity claim that distinguishes an operating factory from a trading or brokerage arrangement. A European buyer evaluating multiple manufacturers can compare these numbers directly against what a competitor is willing to disclose.
A geographic and regulatory position built specifically for European trade. Turkey’s Customs Union status, short transit routes, and manufacturing base with deep pharmaceutical-industry roots aren’t generic advantages — they’re specific to serving European buyers, distinct from the case a manufacturer in India, China, or the US would make.
Full-service export documentation, not just a certificate on request. Beyond holding certifications, HELEX HEALTHCARE prepares the product dossiers and export paperwork brands need for market registration — support that regularly saves brands weeks of back-and-forth with regulators and customs authorities, according to client feedback on other market pages.